GNH USA

Europe — EMA

Letybo

GNH USA supplies Letybo (Botulinum toxin type A), a neuromuscular blocking agent for conditions such as cervical dystonia and chronic migraine.

Botulinum Toxin Type A

Request sourcing

1
Pack/s

What is Botulinum Toxin Type A?

Botulinum toxin type A, the active ingredient in Letybo, is a neuromuscular blocking agent presented as an injectable solution for intramuscular use. It temporarily reduces muscle activity and is employed in several therapeutic areas where abnormal muscle contraction or glandular secretion is problematic.

GNH USA supplies Letybo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Botulinum Toxin Type A used for?

Letybo (botulinum toxin type A) is used to treat disorders involving abnormal muscle activity or glandular secretion.

- Cervical dystonia: reduces involuntary neck muscle contractions. - Blepharospasm: alleviates excessive eyelid closure. - Chronic migraine: decreases the frequency of migraine days. - Upper‑limb spasticity: improves muscle tone and functional movement. - Primary axillary hyperhidrosis: diminishes excessive sweating.

What are the side effects of Botulinum Toxin Type A?

Letybo may cause a range of adverse reactions following intramuscular injection.

Common Side Effects: - Injection site pain or bruising. - Headache. - Transient localized muscle weakness. - Flu‑like symptoms. - Dry mouth. - Mild nausea.

Serious or Rare Side Effects: - Dysphagia or difficulty swallowing. - Respiratory compromise due to spread of toxin. - Generalized muscle weakness. - Allergic reactions including anaphylaxis. - Urinary retention. - Vision changes such as blurred vision.

What precautions apply to Botulinum Toxin Type A?

Before using Letybo, clinicians should consider several safety measures.

- Pregnancy: safety not established; avoid unless benefit outweighs risk. - Breastfeeding: unknown safety; weigh potential risks. - Neuromuscular disorders (e.g., myasthenia gravis): use with caution. - Concurrent aminoglycoside antibiotics: may potentiate neuromuscular blockade. - Known hypersensitivity to botulinum toxin: contraindicated. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Botulinum Toxin Type A interact with?

Letybo can interact with other medicines that affect neuromuscular transmission.

Major Interactions (Avoid): - Aminoglycoside antibiotics: increase risk of prolonged paralysis. - Quinine: potentiates neuromuscular blockade. - General anesthetics such as succinylcholine: may cause extended respiratory weakness.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce therapeutic effect. - Calcium channel blockers: possible additive muscle weakness. - Other botulinum toxin products: cumulative toxicity risk.

Frequently asked questions

What is Letybo used for?+
Letybo is a formulation of botulinum toxin type A indicated for several neuromuscular conditions, including cervical dystonia, blepharospasm, chronic migraine prophylaxis, upper‑limb spasticity, and primary axillary hyperhidrosis. It works by temporarily reducing abnormal muscle activity or excessive sweating.
How does botulinum toxin type A work?+
Botulinum toxin type A cleaves the SNAP‑25 protein, which is required for the release of acetylcholine at the neuromuscular junction. By blocking this neurotransmitter release, the drug produces a reversible chemical denervation, leading to temporary muscle relaxation and reduced glandular secretion.
What is the usual dose of Letybo?+
The dose of Letybo is individualized and determined by the prescribing clinician based on the specific indication, treated muscle groups, and patient characteristics. No fixed regimen is provided; the prescriber sets the appropriate units and injection sites.
Is Letybo safe during pregnancy or breastfeeding?+
Safety data for Letybo in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit justifies the risk. Breastfeeding mothers should consider the unknown exposure to the infant and discuss alternatives with their healthcare provider.
How do I order Letybo from GNH USA?+
To order Letybo, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.
How does Letybo compare with other botulinum toxin products?+
Letybo contains the same active protein (botulinum toxin type A) as other licensed products, but differences may exist in formulation, vial size, and manufacturing processes. Clinical efficacy and safety are comparable when used according to approved indications, while specific handling or storage requirements can vary between brands.
How should Letybo be stored and handled?+
Letybo must be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the product. If the cold‑chain is interrupted, discard the product to maintain potency and safety.
How is Letybo administered?+
Letybo is administered by a qualified healthcare professional via intramuscular injection. The prescriber selects the injection sites, dose (in units), and dilution volume according to the therapeutic indication and patient anatomy. Proper aseptic technique and accurate placement are essential for optimal outcomes.
What are the most serious risks to watch for with Letybo?+
Serious adverse events include dysphagia, respiratory compromise from toxin spread, generalized muscle weakness, severe allergic reactions (including anaphylaxis), urinary retention, and vision changes. Patients should be monitored closely after injection, and any signs of systemic spread require immediate medical attention.
Who should not use Letybo?+
Letybo is contraindicated in individuals with a known hypersensitivity to botulinum toxin type A or any of its excipients. Patients with active infections at the proposed injection site, certain neuromuscular disorders such as myasthenia gravis, or those taking medications that markedly increase neuromuscular blockade should avoid use unless a specialist determines it is safe.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Botulinum Toxin Type A
Route
Intramuscular Use
Manufacturer
Croma Pharma Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU